StockData
Braveheart Bio, Inc. logo

Braveheart Bio, Inc. (BRVE) stock

BRVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$18.78−0.71 (-3.64%)

Close on Nov 17, 2026Market cap $1.69BP/E –Yield –

Braveheart Bio EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.51–
Q2 FY2026Jun 30, 2026-$2.51–
Q3 FY2025Sep 30, 2025-$10.05–
Q2 FY2025Jun 30, 2025-$0.14–

More Braveheart Bio figures

See a number that looks wrong?